Dendritic cells and prospects for transplantation tolerance

Current Opinion in Immunology

Volumn 12, Issue 5, 2000, Pages 528-535

  Fairchild, Paul J ^a   Waldmann, Herman ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE; CELL DIFFERENTIATION; CYTOLOGY; DENDRITIC CELL; GRAFT REJECTION; HUMAN; IMMUNITY; IMMUNOBIOLOGY; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; NONHUMAN; ORGAN DONOR; REVIEW; STEM CELL; TRANSPLANTATION;

EID: 0033812843     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(00)00134-5     Document Type: Review

References (77)

1. The dendritic cell system and its role in immunogenicity
2. Dendritic cells and the control of immunity
3. Dendritic cells and the balance between transplant tolerance and immunity
4. Dendritic cells as regulators of immune reactivity: Implications for transplantation
5. Transplantation tolerance - Where do we stand?
6. Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer
7. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion
8. + T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells
9. Constitutive class I-restricted exogenous presentation of self antigens in vivo
10. + T cells
11. + T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1)
12. Cross tolerance: A pathway for inducing tolerance to peripheral tissue antigens
13. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation
14. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells
15. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction
16. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
17. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes
18. The induction of tolerance by dendritic cells that have captured apoptotic cells
19. Dendritic cells
20. The control of T cell responses by dendritic cell subsets
21. Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity
22. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells
23. Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo
24. Are dendritic cells the key to liver transplant tolerance?
25. Dendritic cell development: Multiple pathways to nature's adjuvants
26. Dendritic cells in the T-cell areas of lymphoid organs
27. High levels of major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes
28. The evolution of self-tolerance: A new cell arises to meet the challenge of self-reactivity
29. - cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers
30. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo
31. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo
32. Reciprocal control of T helper cell and dendritic cell differentiation
33. Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction
34. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli
35. Transport of peptide-MHC class II complexes in developing dendritic cells
36. + T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity
37. + T-helper cell and a T-killer cell
38. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
39. T-cell help for CTL is mediated by CD40-CD40L interactions
40. Dendritic cells require maturation via CD40 to generate protective antitumor immunity
41. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
42. Natural adjuvants: Endogenous activators of dendritic cells
43. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function
44. Immunogenicity of apoptotic cells in vivo: Role of antigen load, antigen-presenting cells, and cytokines
45. -) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes
46. -) prolong cardiac allograft survival in non-immunosuppressed recipients
47. Monocyte-derived dendritic cell precursors facilitate tolerance to heart allografts after total lymphoid irradiation
48. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival
49. + T Cell tolerance and linked suppression
50. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154
51. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
52. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance
53. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance
54. An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow
55. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation
56. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
57. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
58. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation
59. Inhibition of T Cell proliferation by macrophage tryptophan catabolism
60. Linked suppression of skin graft rejection can operate through indirect recognition
61. Anti-inflammatory effects of CD95 ligand (FasL)-induced apoptosis
62. Immunosuppressive effects of apoptotic cells
63. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells
64. Other functions, other genes: Alternative activation of antigen-presenting cells
65. Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells
66. Induction of tolerance by IL-10-treated dendritic cells
67. + T cells resulting in a failure to lyse tumor cells
68. Induction of antigen-specific immunosuppression by CD95L cDNA-transfected 'killer' dendritic cells
69. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival
70. Genetic engineering of dendritic cells to express immunosuppressive molecules (viral IL-10, TGF-β, and CTLA4lg)
71. What is the role of regulatory T cells in transplantation tolerance?
72. Serial analysis of gene expression in human monocyte-derived dendritic cells
73. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo
74. In vivo and in vitro modulation of immune stimulatory capacity of primary dendritic cells by adenovirus-mediated gene transduction
75. Production of homozygous mutant ES cells with a single targeting construct
76. + T cells
77. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival